<- Go Home

TearLab Corporation

TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. The company offers TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab Pen, a hand-held device that interfaces with the TearLab disposable; and TearLab Reader, a small desktop unit that allows for the docking of the TearLab Pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in Southlake, Texas.

Market Cap

$1.4M

Volume

34.6K

Cash and Equivalents

$7.3M

EBITDA

$767.3K

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$14.3M

Profit Margin

64.76%

52 Week High

$0.21

52 Week Low

$0.02

Dividend

N/A

Price / Book Value

-0.03

Price / Earnings

-0.13

Price / Tangible Book Value

-0.03

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

$128.0K

Return on Equity

22.78%

Return on Assets

0.54

Cash and Short Term Investments

$7.3M

Debt

$38.6M

Equity

-$27.6M

Revenue

$22.1M

Unlevered FCF

-$578.7K

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches